Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиCalithera Biosciences Мультипликаторы 2011-2024 | CALA
Мультипликаторы по годам Calithera Biosciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-8.3 | -2.2 | -3.3 | -2.9 | -9.4 | -3.5 | -2.8 | -16.4 | - | - | - |
P/S |
98.5 | - | - | 7.2 | 10.1 | - | - | - | - | - | - |
EPS |
- | - | - | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
916 млн | 114 млн | 259 млн | 125 млн | 256 млн | 126 млн | 88.1 млн | 259 млн | 21.8 млн | 9.43 млн | - |
EBITDA per Share |
-1.56 | -1.32 | -1.95 | -1.55 | -0.89 | -1.95 | -1.8 | -1.19 | - | - | - |
EV/EBITDA |
-8.0 | -1.1 | -2.5 | -1.9 | -7.3 | -3.2 | -2.6 | -11.9 | - | - | - |
PEG |
-1.33 | -0.07 | 0.12 | 0.04 | -0.17 | 0.45 | 0.06 | -0.27 | - | - | - |
P/B |
19.6 | 1.9 | 2.1 | 1.3 | 1.7 | 2.6 | 1.3 | 3.6 | - | - | - |
P/CF |
-14.5 | -2.3 | -3.7 | -2.5 | 20.9 | -4.2 | -3.0 | -18.0 | - | - | - |
ROE % |
-1373.04 | -88.05 | -63.09 | -43.11 | -18.51 | -76.15 | -45.47 | -21.63 | - | - | - |
ROA % |
-177.73 | -71.77 | -53.24 | -38.28 | -14.46 | -69.36 | -43.09 | -20.72 | - | - | - |
ROCE % |
-1377.15 | -85.26 | -62.29 | -44.81 | -19.35 | -76.15 | -45.63 | -21.58 | - | - | - |
Current Ratio |
4.1 | 6.5 | 8.1 | 9.4 | 4.3 | 12.0 | 18.9 | 25.2 | - | - | - |
DSO |
28.8 | - | - | 32.8 | 16.1 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
28.8 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
28.8 | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Calithera Biosciences
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -2.01 | 1.63 | - | - | -3.01 | -3.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -1.92 | -2.31 | -0.18 | - | -2.95 | -3.82 | -0.29 | - | -0.32 | -0.3 | -0.39 | - | -0.39 | -0.6 | -0.62 | - | -0.53 | -0.1 | -0.38 | - | -0.18 | -0.16 | -0.22 | - | -0.43 | -0.54 | -0.52 | - | -0.48 | -0.43 | -0.43 | - | -16 | -23.5 | -22.4 | - | -32 | - | - | - | - | - | - | - | - | - | - |
ROE % |
378.27 | 363.26 | 385.39 | 393.90 | -53.91 | -76.12 | -83.31 | -85.99 | -66.01 | -81.26 | -73.30 | -70.34 | -63.09 | -63.22 | -63.85 | -49.32 | -43.11 | -35.02 | -24.19 | -25.22 | -18.51 | -30.29 | -43.37 | -60.67 | -76.15 | -68.31 | -63.59 | -53.73 | -45.47 | -41.04 | -33.86 | -28.45 | -21.63 | 1.12 | 22.28 | 27.75 | 15.94 | 15.94 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-73.90 | -86.31 | -72.30 | -67.00 | -45.47 | -63.57 | -69.26 | -70.87 | -53.80 | -66.68 | -60.60 | -58.67 | -53.24 | -54.03 | -55.21 | -43.06 | -38.28 | -30.32 | -20.26 | -20.81 | -14.46 | -26.13 | -38.57 | -54.77 | -69.36 | -62.63 | -58.79 | -50.21 | -43.09 | -38.97 | -32.22 | -27.14 | -20.72 | -23.72 | -28.25 | -23.00 | -9.52 | -9.52 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
372.51 | 357.53 | 378.64 | 393.68 | -54.27 | -76.64 | -84.03 | -87.07 | -67.13 | -81.97 | -74.43 | -71.65 | -49.46 | -64.85 | -65.41 | -50.87 | -29.24 | -33.67 | -22.70 | -23.57 | -12.07 | -29.37 | -42.24 | -59.34 | -57.57 | -70.04 | -65.21 | -55.25 | -34.39 | -39.60 | -32.34 | -26.84 | -14.81 | 1.13 | 22.28 | 27.75 | 15.94 | 15.94 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 3.5 | 4.4 | 4.0 | 4.1 | 5.8 | 6.6 | 6.7 | 5.4 | 5.4 | 5.4 | 5.4 | 6.4 | 6.4 | 6.4 | 6.4 | 8.9 | 8.9 | 8.9 | 8.9 | 4.6 | 4.6 | 4.6 | 4.6 | 11.2 | 11.2 | 11.2 | 11.2 | 19.1 | 19.1 | 19.1 | 19.1 | 23.8 | 23.8 | 23.8 | 23.8 | 25.3 | 25.3 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | 0.2 | 15.8 | - | - | - | - | - | - | - | - | - | - | 8.2 | 10.7 | 27.6 | 14.4 | 14.4 | 14.4 | 12.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | 0.2 | 15.8 | - | - | - | - | - | - | - | - | - | - | 8.2 | 10.7 | 27.6 | 14.4 | 14.4 | 14.4 | 12.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | 0.2 | 15.8 | - | - | - | - | - | - | - | - | - | - | 8.2 | 10.7 | 27.6 | 14.4 | 14.4 | 14.4 | 12.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD